nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—CYP2D6—Alzheimer's disease	0.342	1	CbGaD
Quinidine barbiturate—CYP2D6—Rivastigmine—Alzheimer's disease	0.111	0.432	CbGbCtD
Quinidine barbiturate—CYP2D6—Donepezil—Alzheimer's disease	0.0889	0.345	CbGbCtD
Quinidine barbiturate—CYP2D6—Galantamine—Alzheimer's disease	0.0573	0.223	CbGbCtD
Quinidine barbiturate—KCNK1—forebrain—Alzheimer's disease	0.00345	0.0588	CbGeAlD
Quinidine barbiturate—GRIA2—embryo—Alzheimer's disease	0.00317	0.0541	CbGeAlD
Quinidine barbiturate—KCNK1—telencephalon—Alzheimer's disease	0.00317	0.0541	CbGeAlD
Quinidine barbiturate—GRIA2—forebrain—Alzheimer's disease	0.0028	0.0479	CbGeAlD
Quinidine barbiturate—GRIA2—telencephalon—Alzheimer's disease	0.00258	0.044	CbGeAlD
Quinidine barbiturate—KCNK1—nervous system—Alzheimer's disease	0.00187	0.0319	CbGeAlD
Quinidine barbiturate—GABRA2—forebrain—Alzheimer's disease	0.00182	0.0311	CbGeAlD
Quinidine barbiturate—KCNK1—central nervous system—Alzheimer's disease	0.0018	0.0307	CbGeAlD
Quinidine barbiturate—GABRA1—forebrain—Alzheimer's disease	0.00176	0.0301	CbGeAlD
Quinidine barbiturate—KCNK1—cerebellum—Alzheimer's disease	0.00176	0.03	CbGeAlD
Quinidine barbiturate—CHRM2—forebrain—Alzheimer's disease	0.00175	0.0299	CbGeAlD
Quinidine barbiturate—GABRA2—telencephalon—Alzheimer's disease	0.00168	0.0286	CbGeAlD
Quinidine barbiturate—GABRA1—telencephalon—Alzheimer's disease	0.00162	0.0276	CbGeAlD
Quinidine barbiturate—CHRM2—telencephalon—Alzheimer's disease	0.00161	0.0275	CbGeAlD
Quinidine barbiturate—GRIA2—nervous system—Alzheimer's disease	0.00152	0.026	CbGeAlD
Quinidine barbiturate—GRIA2—central nervous system—Alzheimer's disease	0.00147	0.025	CbGeAlD
Quinidine barbiturate—GRIA2—cerebellum—Alzheimer's disease	0.00143	0.0244	CbGeAlD
Quinidine barbiturate—KCNK1—brain—Alzheimer's disease	0.00143	0.0244	CbGeAlD
Quinidine barbiturate—KCNH2—forebrain—Alzheimer's disease	0.00127	0.0216	CbGeAlD
Quinidine barbiturate—GRIA2—brain—Alzheimer's disease	0.00116	0.0199	CbGeAlD
Quinidine barbiturate—KCNH2—telencephalon—Alzheimer's disease	0.00116	0.0199	CbGeAlD
Quinidine barbiturate—SCN5A—nervous system—Alzheimer's disease	0.00112	0.0191	CbGeAlD
Quinidine barbiturate—Phenobarbital—CHRNA7—Alzheimer's disease	0.00111	0.245	CrCbGaD
Quinidine barbiturate—SCN5A—central nervous system—Alzheimer's disease	0.00108	0.0184	CbGeAlD
Quinidine barbiturate—Phenobarbital—GRIK2—Alzheimer's disease	0.00104	0.229	CrCbGaD
Quinidine barbiturate—GABRA2—nervous system—Alzheimer's disease	0.000989	0.0169	CbGeAlD
Quinidine barbiturate—GABRA1—nervous system—Alzheimer's disease	0.000956	0.0163	CbGeAlD
Quinidine barbiturate—GABRA2—central nervous system—Alzheimer's disease	0.000953	0.0163	CbGeAlD
Quinidine barbiturate—CHRM2—nervous system—Alzheimer's disease	0.000951	0.0162	CbGeAlD
Quinidine barbiturate—GABRA2—cerebellum—Alzheimer's disease	0.000931	0.0159	CbGeAlD
Quinidine barbiturate—GABRA1—central nervous system—Alzheimer's disease	0.000921	0.0157	CbGeAlD
Quinidine barbiturate—CHRM2—central nervous system—Alzheimer's disease	0.000916	0.0156	CbGeAlD
Quinidine barbiturate—GABRA1—cerebellum—Alzheimer's disease	0.0009	0.0154	CbGeAlD
Quinidine barbiturate—Phenobarbital—CHRNA4—Alzheimer's disease	0.000888	0.196	CrCbGaD
Quinidine barbiturate—SCN5A—brain—Alzheimer's disease	0.000854	0.0146	CbGeAlD
Quinidine barbiturate—Quinine—CYP2D6—Alzheimer's disease	0.000794	0.175	CrCbGaD
Quinidine barbiturate—CYP2D6—forebrain—Alzheimer's disease	0.000772	0.0132	CbGeAlD
Quinidine barbiturate—GABRA2—brain—Alzheimer's disease	0.000756	0.0129	CbGeAlD
Quinidine barbiturate—GABRA1—brain—Alzheimer's disease	0.000731	0.0125	CbGeAlD
Quinidine barbiturate—CHRM2—brain—Alzheimer's disease	0.000727	0.0124	CbGeAlD
Quinidine barbiturate—CYP2D6—telencephalon—Alzheimer's disease	0.00071	0.0121	CbGeAlD
Quinidine barbiturate—Quinidine—CYP2D6—Alzheimer's disease	0.000698	0.154	CrCbGaD
Quinidine barbiturate—KCNH2—nervous system—Alzheimer's disease	0.000687	0.0117	CbGeAlD
Quinidine barbiturate—KCNH2—central nervous system—Alzheimer's disease	0.000661	0.0113	CbGeAlD
Quinidine barbiturate—KCNH2—cerebellum—Alzheimer's disease	0.000646	0.011	CbGeAlD
Quinidine barbiturate—Muscular weakness—Memantine—Alzheimer's disease	0.0006	0.00252	CcSEcCtD
Quinidine barbiturate—Asthma—Memantine—Alzheimer's disease	0.000588	0.00247	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Rivastigmine—Alzheimer's disease	0.000587	0.00247	CcSEcCtD
Quinidine barbiturate—Mental disorder—Galantamine—Alzheimer's disease	0.000585	0.00246	CcSEcCtD
Quinidine barbiturate—Malnutrition—Galantamine—Alzheimer's disease	0.000582	0.00245	CcSEcCtD
Quinidine barbiturate—Bronchospasm—Memantine—Alzheimer's disease	0.000578	0.00243	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Memantine—Alzheimer's disease	0.000572	0.00241	CcSEcCtD
Quinidine barbiturate—Tension—Galantamine—Alzheimer's disease	0.000571	0.0024	CcSEcCtD
Quinidine barbiturate—Renal failure—Donepezil—Alzheimer's disease	0.000567	0.00238	CcSEcCtD
Quinidine barbiturate—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000565	0.00238	CcSEcCtD
Quinidine barbiturate—Nervousness—Galantamine—Alzheimer's disease	0.000565	0.00238	CcSEcCtD
Quinidine barbiturate—Jaundice—Donepezil—Alzheimer's disease	0.000562	0.00236	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00056	0.00235	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Memantine—Alzheimer's disease	0.000558	0.00235	CcSEcCtD
Quinidine barbiturate—Sweating—Donepezil—Alzheimer's disease	0.000553	0.00233	CcSEcCtD
Quinidine barbiturate—Neutropenia—Memantine—Alzheimer's disease	0.000549	0.00231	CcSEcCtD
Quinidine barbiturate—Vision blurred—Galantamine—Alzheimer's disease	0.000548	0.00231	CcSEcCtD
Quinidine barbiturate—Tremor—Galantamine—Alzheimer's disease	0.000545	0.00229	CcSEcCtD
Quinidine barbiturate—Agitation—Galantamine—Alzheimer's disease	0.000535	0.00225	CcSEcCtD
Quinidine barbiturate—Bradycardia—Donepezil—Alzheimer's disease	0.000527	0.00222	CcSEcCtD
Quinidine barbiturate—KCNH2—brain—Alzheimer's disease	0.000525	0.00896	CbGeAlD
Quinidine barbiturate—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000525	0.00221	CcSEcCtD
Quinidine barbiturate—Vertigo—Galantamine—Alzheimer's disease	0.000523	0.0022	CcSEcCtD
Quinidine barbiturate—Syncope—Galantamine—Alzheimer's disease	0.000522	0.00219	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Donepezil—Alzheimer's disease	0.000521	0.00219	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000519	0.00218	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Donepezil—Alzheimer's disease	0.000518	0.00218	CcSEcCtD
Quinidine barbiturate—Hepatitis—Donepezil—Alzheimer's disease	0.000518	0.00218	CcSEcCtD
Quinidine barbiturate—Hallucination—Donepezil—Alzheimer's disease	0.000515	0.00217	CcSEcCtD
Quinidine barbiturate—Renal failure—Memantine—Alzheimer's disease	0.000515	0.00216	CcSEcCtD
Quinidine barbiturate—Palpitations—Galantamine—Alzheimer's disease	0.000514	0.00216	CcSEcCtD
Quinidine barbiturate—Drowsiness—Rivastigmine—Alzheimer's disease	0.000512	0.00215	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000511	0.00215	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Galantamine—Alzheimer's disease	0.000511	0.00215	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000508	0.00214	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Donepezil—Alzheimer's disease	0.000508	0.00213	CcSEcCtD
Quinidine barbiturate—Convulsion—Galantamine—Alzheimer's disease	0.000504	0.00212	CcSEcCtD
Quinidine barbiturate—Renal failure—Rivastigmine—Alzheimer's disease	0.000504	0.00212	CcSEcCtD
Quinidine barbiturate—Visual impairment—Donepezil—Alzheimer's disease	0.000499	0.0021	CcSEcCtD
Quinidine barbiturate—Chest pain—Galantamine—Alzheimer's disease	0.000495	0.00208	CcSEcCtD
Quinidine barbiturate—Arthralgia—Galantamine—Alzheimer's disease	0.000495	0.00208	CcSEcCtD
Quinidine barbiturate—Myalgia—Galantamine—Alzheimer's disease	0.000495	0.00208	CcSEcCtD
Quinidine barbiturate—Anxiety—Galantamine—Alzheimer's disease	0.000494	0.00208	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000492	0.00207	CcSEcCtD
Quinidine barbiturate—Sweating—Rivastigmine—Alzheimer's disease	0.000491	0.00207	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Memantine—Alzheimer's disease	0.000489	0.00206	CcSEcCtD
Quinidine barbiturate—Tinnitus—Donepezil—Alzheimer's disease	0.000483	0.00203	CcSEcCtD
Quinidine barbiturate—Confusional state—Galantamine—Alzheimer's disease	0.000479	0.00201	CcSEcCtD
Quinidine barbiturate—Bradycardia—Memantine—Alzheimer's disease	0.000479	0.00201	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Memantine—Alzheimer's disease	0.000473	0.00199	CcSEcCtD
Quinidine barbiturate—Hepatitis—Memantine—Alzheimer's disease	0.00047	0.00198	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Memantine—Alzheimer's disease	0.00047	0.00198	CcSEcCtD
Quinidine barbiturate—Bradycardia—Rivastigmine—Alzheimer's disease	0.000468	0.00197	CcSEcCtD
Quinidine barbiturate—Hallucination—Memantine—Alzheimer's disease	0.000468	0.00197	CcSEcCtD
Quinidine barbiturate—Shock—Galantamine—Alzheimer's disease	0.000467	0.00196	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Galantamine—Alzheimer's disease	0.000466	0.00196	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000465	0.00195	CcSEcCtD
Quinidine barbiturate—Chills—Donepezil—Alzheimer's disease	0.000465	0.00195	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Memantine—Alzheimer's disease	0.000464	0.00195	CcSEcCtD
Quinidine barbiturate—Tachycardia—Galantamine—Alzheimer's disease	0.000463	0.00195	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000462	0.00194	CcSEcCtD
Quinidine barbiturate—Skin disorder—Galantamine—Alzheimer's disease	0.000461	0.00194	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Memantine—Alzheimer's disease	0.000461	0.00194	CcSEcCtD
Quinidine barbiturate—Hepatitis—Rivastigmine—Alzheimer's disease	0.00046	0.00193	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00046	0.00193	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000459	0.00193	CcSEcCtD
Quinidine barbiturate—Hallucination—Rivastigmine—Alzheimer's disease	0.000458	0.00192	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000454	0.00191	CcSEcCtD
Quinidine barbiturate—Mental disorder—Donepezil—Alzheimer's disease	0.000454	0.00191	CcSEcCtD
Quinidine barbiturate—Visual impairment—Memantine—Alzheimer's disease	0.000453	0.00191	CcSEcCtD
Quinidine barbiturate—Anorexia—Galantamine—Alzheimer's disease	0.000453	0.0019	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000451	0.0019	CcSEcCtD
Quinidine barbiturate—Malnutrition—Donepezil—Alzheimer's disease	0.000451	0.0019	CcSEcCtD
Quinidine barbiturate—Erythema—Donepezil—Alzheimer's disease	0.000451	0.0019	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Memantine—Alzheimer's disease	0.000445	0.00187	CcSEcCtD
Quinidine barbiturate—Hypotension—Galantamine—Alzheimer's disease	0.000444	0.00187	CcSEcCtD
Quinidine barbiturate—Visual impairment—Rivastigmine—Alzheimer's disease	0.000443	0.00186	CcSEcCtD
Quinidine barbiturate—Tension—Donepezil—Alzheimer's disease	0.000442	0.00186	CcSEcCtD
Quinidine barbiturate—Eye disorder—Memantine—Alzheimer's disease	0.000439	0.00185	CcSEcCtD
Quinidine barbiturate—Tinnitus—Memantine—Alzheimer's disease	0.000438	0.00184	CcSEcCtD
Quinidine barbiturate—Nervousness—Donepezil—Alzheimer's disease	0.000438	0.00184	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Memantine—Alzheimer's disease	0.000436	0.00183	CcSEcCtD
Quinidine barbiturate—Flushing—Memantine—Alzheimer's disease	0.000436	0.00183	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000435	0.00183	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000433	0.00182	CcSEcCtD
Quinidine barbiturate—Eye disorder—Rivastigmine—Alzheimer's disease	0.00043	0.00181	CcSEcCtD
Quinidine barbiturate—Tinnitus—Rivastigmine—Alzheimer's disease	0.000429	0.0018	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000427	0.0018	CcSEcCtD
Quinidine barbiturate—Flushing—Rivastigmine—Alzheimer's disease	0.000427	0.0018	CcSEcCtD
Quinidine barbiturate—Vision blurred—Donepezil—Alzheimer's disease	0.000425	0.00179	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Memantine—Alzheimer's disease	0.000425	0.00179	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Memantine—Alzheimer's disease	0.000424	0.00178	CcSEcCtD
Quinidine barbiturate—Tremor—Donepezil—Alzheimer's disease	0.000422	0.00178	CcSEcCtD
Quinidine barbiturate—Somnolence—Galantamine—Alzheimer's disease	0.000422	0.00177	CcSEcCtD
Quinidine barbiturate—Chills—Memantine—Alzheimer's disease	0.000422	0.00177	CcSEcCtD
Quinidine barbiturate—CYP2D6—nervous system—Alzheimer's disease	0.000419	0.00715	CbGeAlD
Quinidine barbiturate—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000415	0.00174	CcSEcCtD
Quinidine barbiturate—Agitation—Donepezil—Alzheimer's disease	0.000414	0.00174	CcSEcCtD
Quinidine barbiturate—Chills—Rivastigmine—Alzheimer's disease	0.000413	0.00174	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Galantamine—Alzheimer's disease	0.000413	0.00174	CcSEcCtD
Quinidine barbiturate—Mental disorder—Memantine—Alzheimer's disease	0.000412	0.00173	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00041	0.00172	CcSEcCtD
Quinidine barbiturate—Malnutrition—Memantine—Alzheimer's disease	0.000409	0.00172	CcSEcCtD
Quinidine barbiturate—Constipation—Galantamine—Alzheimer's disease	0.000406	0.00171	CcSEcCtD
Quinidine barbiturate—Vertigo—Donepezil—Alzheimer's disease	0.000405	0.0017	CcSEcCtD
Quinidine barbiturate—Syncope—Donepezil—Alzheimer's disease	0.000404	0.0017	CcSEcCtD
Quinidine barbiturate—CYP2D6—central nervous system—Alzheimer's disease	0.000403	0.00688	CbGeAlD
Quinidine barbiturate—Mental disorder—Rivastigmine—Alzheimer's disease	0.000403	0.00169	CcSEcCtD
Quinidine barbiturate—Tension—Memantine—Alzheimer's disease	0.000402	0.00169	CcSEcCtD
Quinidine barbiturate—Malnutrition—Rivastigmine—Alzheimer's disease	0.0004	0.00168	CcSEcCtD
Quinidine barbiturate—Erythema—Rivastigmine—Alzheimer's disease	0.0004	0.00168	CcSEcCtD
Quinidine barbiturate—Nervousness—Memantine—Alzheimer's disease	0.000398	0.00167	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Donepezil—Alzheimer's disease	0.000396	0.00167	CcSEcCtD
Quinidine barbiturate—CYP2D6—cerebellum—Alzheimer's disease	0.000394	0.00673	CbGeAlD
Quinidine barbiturate—Tension—Rivastigmine—Alzheimer's disease	0.000393	0.00165	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Galantamine—Alzheimer's disease	0.000391	0.00164	CcSEcCtD
Quinidine barbiturate—Convulsion—Donepezil—Alzheimer's disease	0.000391	0.00164	CcSEcCtD
Quinidine barbiturate—Nervousness—Rivastigmine—Alzheimer's disease	0.000389	0.00164	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000388	0.00163	CcSEcCtD
Quinidine barbiturate—Vision blurred—Memantine—Alzheimer's disease	0.000386	0.00162	CcSEcCtD
Quinidine barbiturate—Myalgia—Donepezil—Alzheimer's disease	0.000384	0.00161	CcSEcCtD
Quinidine barbiturate—Arthralgia—Donepezil—Alzheimer's disease	0.000384	0.00161	CcSEcCtD
Quinidine barbiturate—Chest pain—Donepezil—Alzheimer's disease	0.000384	0.00161	CcSEcCtD
Quinidine barbiturate—Tremor—Memantine—Alzheimer's disease	0.000384	0.00161	CcSEcCtD
Quinidine barbiturate—Anxiety—Donepezil—Alzheimer's disease	0.000383	0.00161	CcSEcCtD
Quinidine barbiturate—Vision blurred—Rivastigmine—Alzheimer's disease	0.000377	0.00159	CcSEcCtD
Quinidine barbiturate—Agitation—Memantine—Alzheimer's disease	0.000376	0.00158	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Galantamine—Alzheimer's disease	0.000375	0.00158	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Galantamine—Alzheimer's disease	0.000375	0.00158	CcSEcCtD
Quinidine barbiturate—Tremor—Rivastigmine—Alzheimer's disease	0.000375	0.00158	CcSEcCtD
Quinidine barbiturate—Confusional state—Donepezil—Alzheimer's disease	0.000371	0.00156	CcSEcCtD
Quinidine barbiturate—Agitation—Rivastigmine—Alzheimer's disease	0.000368	0.00155	CcSEcCtD
Quinidine barbiturate—Oedema—Donepezil—Alzheimer's disease	0.000368	0.00155	CcSEcCtD
Quinidine barbiturate—Vertigo—Memantine—Alzheimer's disease	0.000368	0.00155	CcSEcCtD
Quinidine barbiturate—Syncope—Memantine—Alzheimer's disease	0.000367	0.00154	CcSEcCtD
Quinidine barbiturate—Leukopenia—Memantine—Alzheimer's disease	0.000366	0.00154	CcSEcCtD
Quinidine barbiturate—Shock—Donepezil—Alzheimer's disease	0.000362	0.00152	CcSEcCtD
Quinidine barbiturate—Palpitations—Memantine—Alzheimer's disease	0.000362	0.00152	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Donepezil—Alzheimer's disease	0.000361	0.00152	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00036	0.00151	CcSEcCtD
Quinidine barbiturate—Vertigo—Rivastigmine—Alzheimer's disease	0.00036	0.00151	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Memantine—Alzheimer's disease	0.00036	0.00151	CcSEcCtD
Quinidine barbiturate—Syncope—Rivastigmine—Alzheimer's disease	0.000359	0.00151	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000356	0.0015	CcSEcCtD
Quinidine barbiturate—Convulsion—Memantine—Alzheimer's disease	0.000355	0.00149	CcSEcCtD
Quinidine barbiturate—Palpitations—Rivastigmine—Alzheimer's disease	0.000354	0.00149	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000352	0.00148	CcSEcCtD
Quinidine barbiturate—Anorexia—Donepezil—Alzheimer's disease	0.000351	0.00147	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Galantamine—Alzheimer's disease	0.00035	0.00147	CcSEcCtD
Quinidine barbiturate—Myalgia—Memantine—Alzheimer's disease	0.000349	0.00147	CcSEcCtD
Quinidine barbiturate—Arthralgia—Memantine—Alzheimer's disease	0.000349	0.00147	CcSEcCtD
Quinidine barbiturate—Chest pain—Memantine—Alzheimer's disease	0.000349	0.00147	CcSEcCtD
Quinidine barbiturate—Anxiety—Memantine—Alzheimer's disease	0.000347	0.00146	CcSEcCtD
Quinidine barbiturate—Convulsion—Rivastigmine—Alzheimer's disease	0.000347	0.00146	CcSEcCtD
Quinidine barbiturate—Hypotension—Donepezil—Alzheimer's disease	0.000344	0.00145	CcSEcCtD
Quinidine barbiturate—Arthralgia—Rivastigmine—Alzheimer's disease	0.000341	0.00143	CcSEcCtD
Quinidine barbiturate—Chest pain—Rivastigmine—Alzheimer's disease	0.000341	0.00143	CcSEcCtD
Quinidine barbiturate—Myalgia—Rivastigmine—Alzheimer's disease	0.000341	0.00143	CcSEcCtD
Quinidine barbiturate—Asthenia—Galantamine—Alzheimer's disease	0.000341	0.00143	CcSEcCtD
Quinidine barbiturate—Anxiety—Rivastigmine—Alzheimer's disease	0.00034	0.00143	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000339	0.00142	CcSEcCtD
Quinidine barbiturate—Confusional state—Memantine—Alzheimer's disease	0.000337	0.00142	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000335	0.00141	CcSEcCtD
Quinidine barbiturate—Oedema—Memantine—Alzheimer's disease	0.000334	0.0014	CcSEcCtD
Quinidine barbiturate—Confusional state—Rivastigmine—Alzheimer's disease	0.00033	0.00139	CcSEcCtD
Quinidine barbiturate—Shock—Memantine—Alzheimer's disease	0.000329	0.00138	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Donepezil—Alzheimer's disease	0.000328	0.00138	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Memantine—Alzheimer's disease	0.000328	0.00138	CcSEcCtD
Quinidine barbiturate—Somnolence—Donepezil—Alzheimer's disease	0.000327	0.00138	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Memantine—Alzheimer's disease	0.000327	0.00138	CcSEcCtD
Quinidine barbiturate—Oedema—Rivastigmine—Alzheimer's disease	0.000327	0.00137	CcSEcCtD
Quinidine barbiturate—Tachycardia—Memantine—Alzheimer's disease	0.000326	0.00137	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Galantamine—Alzheimer's disease	0.000325	0.00137	CcSEcCtD
Quinidine barbiturate—Skin disorder—Memantine—Alzheimer's disease	0.000325	0.00136	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Memantine—Alzheimer's disease	0.000323	0.00136	CcSEcCtD
Quinidine barbiturate—Shock—Rivastigmine—Alzheimer's disease	0.000322	0.00135	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000321	0.00135	CcSEcCtD
Quinidine barbiturate—CYP2D6—brain—Alzheimer's disease	0.00032	0.00546	CbGeAlD
Quinidine barbiturate—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00032	0.00135	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Donepezil—Alzheimer's disease	0.00032	0.00134	CcSEcCtD
Quinidine barbiturate—Tachycardia—Rivastigmine—Alzheimer's disease	0.000319	0.00134	CcSEcCtD
Quinidine barbiturate—Anorexia—Memantine—Alzheimer's disease	0.000318	0.00134	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000318	0.00134	CcSEcCtD
Quinidine barbiturate—Skin disorder—Rivastigmine—Alzheimer's disease	0.000317	0.00133	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000316	0.00133	CcSEcCtD
Quinidine barbiturate—Pain—Donepezil—Alzheimer's disease	0.000315	0.00132	CcSEcCtD
Quinidine barbiturate—Constipation—Donepezil—Alzheimer's disease	0.000315	0.00132	CcSEcCtD
Quinidine barbiturate—Dizziness—Galantamine—Alzheimer's disease	0.000314	0.00132	CcSEcCtD
Quinidine barbiturate—Hypotension—Memantine—Alzheimer's disease	0.000312	0.00131	CcSEcCtD
Quinidine barbiturate—Anorexia—Rivastigmine—Alzheimer's disease	0.000312	0.00131	CcSEcCtD
Quinidine barbiturate—Hypotension—Rivastigmine—Alzheimer's disease	0.000305	0.00128	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000304	0.00128	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Donepezil—Alzheimer's disease	0.000303	0.00127	CcSEcCtD
Quinidine barbiturate—Vomiting—Galantamine—Alzheimer's disease	0.000302	0.00127	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000301	0.00127	CcSEcCtD
Quinidine barbiturate—Rash—Galantamine—Alzheimer's disease	0.000299	0.00126	CcSEcCtD
Quinidine barbiturate—Dermatitis—Galantamine—Alzheimer's disease	0.000299	0.00126	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Memantine—Alzheimer's disease	0.000298	0.00125	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000298	0.00125	CcSEcCtD
Quinidine barbiturate—Headache—Galantamine—Alzheimer's disease	0.000297	0.00125	CcSEcCtD
Quinidine barbiturate—Somnolence—Memantine—Alzheimer's disease	0.000297	0.00125	CcSEcCtD
Quinidine barbiturate—Urticaria—Donepezil—Alzheimer's disease	0.000292	0.00123	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000291	0.00123	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Donepezil—Alzheimer's disease	0.000291	0.00122	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Donepezil—Alzheimer's disease	0.000291	0.00122	CcSEcCtD
Quinidine barbiturate—Somnolence—Rivastigmine—Alzheimer's disease	0.000291	0.00122	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Memantine—Alzheimer's disease	0.00029	0.00122	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000288	0.00121	CcSEcCtD
Quinidine barbiturate—Constipation—Memantine—Alzheimer's disease	0.000286	0.0012	CcSEcCtD
Quinidine barbiturate—Pain—Memantine—Alzheimer's disease	0.000286	0.0012	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000284	0.00119	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000282	0.00119	CcSEcCtD
Quinidine barbiturate—Nausea—Galantamine—Alzheimer's disease	0.000282	0.00119	CcSEcCtD
Quinidine barbiturate—Pain—Rivastigmine—Alzheimer's disease	0.000279	0.00118	CcSEcCtD
Quinidine barbiturate—Constipation—Rivastigmine—Alzheimer's disease	0.000279	0.00118	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Memantine—Alzheimer's disease	0.000275	0.00116	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000273	0.00115	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Donepezil—Alzheimer's disease	0.000271	0.00114	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000269	0.00113	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000267	0.00112	CcSEcCtD
Quinidine barbiturate—Urticaria—Memantine—Alzheimer's disease	0.000265	0.00112	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Memantine—Alzheimer's disease	0.000264	0.00111	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Memantine—Alzheimer's disease	0.000264	0.00111	CcSEcCtD
Quinidine barbiturate—Asthenia—Donepezil—Alzheimer's disease	0.000264	0.00111	CcSEcCtD
Quinidine barbiturate—Pruritus—Donepezil—Alzheimer's disease	0.00026	0.00109	CcSEcCtD
Quinidine barbiturate—Urticaria—Rivastigmine—Alzheimer's disease	0.00026	0.00109	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000258	0.00109	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000258	0.00109	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Donepezil—Alzheimer's disease	0.000252	0.00106	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Memantine—Alzheimer's disease	0.000246	0.00103	CcSEcCtD
Quinidine barbiturate—Dizziness—Donepezil—Alzheimer's disease	0.000243	0.00102	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000241	0.00101	CcSEcCtD
Quinidine barbiturate—Asthenia—Memantine—Alzheimer's disease	0.00024	0.00101	CcSEcCtD
Quinidine barbiturate—Pruritus—Memantine—Alzheimer's disease	0.000236	0.000994	CcSEcCtD
Quinidine barbiturate—Asthenia—Rivastigmine—Alzheimer's disease	0.000235	0.000986	CcSEcCtD
Quinidine barbiturate—Vomiting—Donepezil—Alzheimer's disease	0.000234	0.000984	CcSEcCtD
Quinidine barbiturate—Rash—Donepezil—Alzheimer's disease	0.000232	0.000975	CcSEcCtD
Quinidine barbiturate—Dermatitis—Donepezil—Alzheimer's disease	0.000232	0.000975	CcSEcCtD
Quinidine barbiturate—Pruritus—Rivastigmine—Alzheimer's disease	0.000231	0.000972	CcSEcCtD
Quinidine barbiturate—Headache—Donepezil—Alzheimer's disease	0.000231	0.000969	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Memantine—Alzheimer's disease	0.000229	0.000961	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000224	0.00094	CcSEcCtD
Quinidine barbiturate—Dizziness—Memantine—Alzheimer's disease	0.000221	0.000929	CcSEcCtD
Quinidine barbiturate—Nausea—Donepezil—Alzheimer's disease	0.000219	0.000919	CcSEcCtD
Quinidine barbiturate—Dizziness—Rivastigmine—Alzheimer's disease	0.000216	0.000909	CcSEcCtD
Quinidine barbiturate—Vomiting—Memantine—Alzheimer's disease	0.000212	0.000893	CcSEcCtD
Quinidine barbiturate—Rash—Memantine—Alzheimer's disease	0.000211	0.000886	CcSEcCtD
Quinidine barbiturate—Dermatitis—Memantine—Alzheimer's disease	0.00021	0.000885	CcSEcCtD
Quinidine barbiturate—Headache—Memantine—Alzheimer's disease	0.000209	0.00088	CcSEcCtD
Quinidine barbiturate—Vomiting—Rivastigmine—Alzheimer's disease	0.000208	0.000874	CcSEcCtD
Quinidine barbiturate—Rash—Rivastigmine—Alzheimer's disease	0.000206	0.000866	CcSEcCtD
Quinidine barbiturate—Dermatitis—Rivastigmine—Alzheimer's disease	0.000206	0.000866	CcSEcCtD
Quinidine barbiturate—Headache—Rivastigmine—Alzheimer's disease	0.000205	0.000861	CcSEcCtD
Quinidine barbiturate—Nausea—Memantine—Alzheimer's disease	0.000198	0.000834	CcSEcCtD
Quinidine barbiturate—Nausea—Rivastigmine—Alzheimer's disease	0.000194	0.000816	CcSEcCtD
Quinidine barbiturate—GABRA1—Neuronal System—ACHE—Alzheimer's disease	0.000103	0.00103	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—DLG4—Alzheimer's disease	0.000103	0.00103	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—CHRNA4—Alzheimer's disease	0.000102	0.00102	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000102	0.00102	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000101	0.00102	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.000101	0.00101	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—IAPP—Alzheimer's disease	0.000101	0.00101	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—GRIN2B—Alzheimer's disease	0.0001	0.00101	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—PLCB1—Alzheimer's disease	9.92e-05	0.000997	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	9.7e-05	0.000975	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—CASP3—Alzheimer's disease	9.7e-05	0.000974	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	9.59e-05	0.000963	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	9.58e-05	0.000962	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—NPY—Alzheimer's disease	9.47e-05	0.000951	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	9.44e-05	0.000948	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	9.4e-05	0.000944	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	9.24e-05	0.000928	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—PRKCG—Alzheimer's disease	9.21e-05	0.000925	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—CALM1—Alzheimer's disease	9.02e-05	0.000906	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—BCHE—Alzheimer's disease	8.97e-05	0.000901	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—MAPK8—Alzheimer's disease	8.91e-05	0.000896	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—MAOB—Alzheimer's disease	8.86e-05	0.00089	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	8.81e-05	0.000885	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR6—Alzheimer's disease	8.79e-05	0.000883	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—DLG4—Alzheimer's disease	8.75e-05	0.000879	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	8.56e-05	0.00086	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—GRIN2B—Alzheimer's disease	8.55e-05	0.000859	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—PLCB1—Alzheimer's disease	8.46e-05	0.00085	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—DLG4—Alzheimer's disease	8.41e-05	0.000845	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	8.31e-05	0.000835	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	8.29e-05	0.000833	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	8.29e-05	0.000832	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—SST—Alzheimer's disease	8.26e-05	0.00083	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—GRIN2B—Alzheimer's disease	8.22e-05	0.000826	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	8.22e-05	0.000826	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	8.17e-05	0.00082	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—PRKCG—Alzheimer's disease	8.09e-05	0.000813	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	8.05e-05	0.000809	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—APP—Alzheimer's disease	8.05e-05	0.000809	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	8.05e-05	0.000808	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	8.04e-05	0.000807	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—CALM1—Alzheimer's disease	7.96e-05	0.0008	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	7.95e-05	0.000799	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—CREB1—Alzheimer's disease	7.72e-05	0.000775	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	7.6e-05	0.000763	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	7.53e-05	0.000756	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—CP—Alzheimer's disease	7.46e-05	0.00075	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—ADAM10—Alzheimer's disease	7.41e-05	0.000744	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	7.38e-05	0.000741	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—PRKCG—Alzheimer's disease	7.34e-05	0.000737	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GAL—Alzheimer's disease	7.3e-05	0.000733	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	7.23e-05	0.000727	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	7.09e-05	0.000713	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	7.07e-05	0.00071	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	7.04e-05	0.000707	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—CALM1—Alzheimer's disease	7e-05	0.000703	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	6.89e-05	0.000692	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	6.82e-05	0.000685	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—CREB1—Alzheimer's disease	6.82e-05	0.000685	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PPARGC1A—Alzheimer's disease	6.79e-05	0.000682	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—PTGS1—Alzheimer's disease	6.71e-05	0.000674	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—F2—Alzheimer's disease	6.58e-05	0.000661	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	6.57e-05	0.00066	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	6.4e-05	0.000643	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—CP—Alzheimer's disease	6.36e-05	0.000639	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—CALM1—Alzheimer's disease	6.35e-05	0.000638	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—TF—Alzheimer's disease	6.34e-05	0.000637	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—GSK3B—Alzheimer's disease	6.29e-05	0.000632	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—PRKCG—Alzheimer's disease	6.26e-05	0.000629	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—CREB1—Alzheimer's disease	6.24e-05	0.000627	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—LPL—Alzheimer's disease	6.18e-05	0.000621	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MEF2C—Alzheimer's disease	6.13e-05	0.000616	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	6.05e-05	0.000608	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	6.03e-05	0.000606	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PYY—Alzheimer's disease	5.95e-05	0.000598	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	5.84e-05	0.000587	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	5.78e-05	0.00058	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—NPY—Alzheimer's disease	5.73e-05	0.000576	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—IAPP—Alzheimer's disease	5.7e-05	0.000573	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CRH—Alzheimer's disease	5.53e-05	0.000556	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	5.48e-05	0.00055	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	5.46e-05	0.000549	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—CREB1—Alzheimer's disease	5.43e-05	0.000546	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—CALM1—Alzheimer's disease	5.41e-05	0.000544	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—TF—Alzheimer's disease	5.41e-05	0.000543	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PYY—Alzheimer's disease	5.4e-05	0.000543	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CCR5—Alzheimer's disease	5.32e-05	0.000535	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—AKT1—Alzheimer's disease	5.25e-05	0.000528	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—NPS—Alzheimer's disease	5.24e-05	0.000527	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—LEP—Alzheimer's disease	5.18e-05	0.000521	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—SST—Alzheimer's disease	5e-05	0.000503	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR6—Alzheimer's disease	4.97e-05	0.000499	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	4.94e-05	0.000496	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—APP—Alzheimer's disease	4.88e-05	0.00049	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	4.87e-05	0.000489	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	4.84e-05	0.000486	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NOTCH1—Alzheimer's disease	4.78e-05	0.000481	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	4.72e-05	0.000474	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CDK5—Alzheimer's disease	4.69e-05	0.000471	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	4.64e-05	0.000466	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—CREB1—Alzheimer's disease	4.63e-05	0.000466	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PPARG—Alzheimer's disease	4.52e-05	0.000454	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR6—Alzheimer's disease	4.51e-05	0.000453	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—GSK3B—Alzheimer's disease	4.49e-05	0.000451	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CREB1—Alzheimer's disease	4.45e-05	0.000447	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	4.44e-05	0.000446	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—INS—Alzheimer's disease	4.43e-05	0.000445	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	4.29e-05	0.000431	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	4.28e-05	0.00043	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	4.23e-05	0.000425	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	4.14e-05	0.000416	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GAL—Alzheimer's disease	4.13e-05	0.000414	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	3.97e-05	0.000399	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—VEGFA—Alzheimer's disease	3.92e-05	0.000394	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	3.81e-05	0.000382	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	3.78e-05	0.00038	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GAL—Alzheimer's disease	3.75e-05	0.000376	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TTR—Alzheimer's disease	3.65e-05	0.000367	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	3.63e-05	0.000365	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	3.63e-05	0.000365	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—NPY—Alzheimer's disease	3.24e-05	0.000326	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	3.24e-05	0.000325	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CA4—Alzheimer's disease	3.24e-05	0.000325	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCR5—Alzheimer's disease	3.22e-05	0.000324	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IAPP—Alzheimer's disease	3.22e-05	0.000324	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	3.21e-05	0.000322	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PYY—Alzheimer's disease	3.19e-05	0.000321	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR2A—Alzheimer's disease	3.15e-05	0.000317	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CRH—Alzheimer's disease	3.13e-05	0.000314	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	3.11e-05	0.000312	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	3.04e-05	0.000306	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—NPS—Alzheimer's disease	2.96e-05	0.000298	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—NPY—Alzheimer's disease	2.94e-05	0.000296	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IAPP—Alzheimer's disease	2.92e-05	0.000294	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	2.88e-05	0.00029	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CRH—Alzheimer's disease	2.84e-05	0.000285	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GAB2—Alzheimer's disease	2.83e-05	0.000284	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—SST—Alzheimer's disease	2.83e-05	0.000284	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—VEGFA—Alzheimer's disease	2.8e-05	0.000281	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDK5—Alzheimer's disease	2.77e-05	0.000278	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—F2—Alzheimer's disease	2.77e-05	0.000278	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—APP—Alzheimer's disease	2.76e-05	0.000277	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PLD3—Alzheimer's disease	2.75e-05	0.000276	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—IL6—Alzheimer's disease	2.71e-05	0.000272	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—NPS—Alzheimer's disease	2.69e-05	0.00027	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.68e-05	0.000269	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR6—Alzheimer's disease	2.66e-05	0.000268	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	2.64e-05	0.000265	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.6e-05	0.000261	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TGFB1—Alzheimer's disease	2.57e-05	0.000258	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—SST—Alzheimer's disease	2.57e-05	0.000258	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GAB2—Alzheimer's disease	2.57e-05	0.000258	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	2.54e-05	0.000255	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.51e-05	0.000252	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—APP—Alzheimer's disease	2.5e-05	0.000251	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CCL2—Alzheimer's disease	2.47e-05	0.000248	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ND1—Alzheimer's disease	2.45e-05	0.000246	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PSENEN—Alzheimer's disease	2.42e-05	0.000243	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TNF—Alzheimer's disease	2.4e-05	0.000241	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APH1A—Alzheimer's disease	2.39e-05	0.00024	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PLCB1—Alzheimer's disease	2.36e-05	0.000237	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NCSTN—Alzheimer's disease	2.32e-05	0.000233	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LRP1—Alzheimer's disease	2.27e-05	0.000228	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GFAP—Alzheimer's disease	2.21e-05	0.000222	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GAL—Alzheimer's disease	2.21e-05	0.000222	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—A2M—Alzheimer's disease	1.95e-05	0.000196	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—IL6—Alzheimer's disease	1.94e-05	0.000194	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.92e-05	0.000193	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PSEN2—Alzheimer's disease	1.89e-05	0.00019	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CCR5—Alzheimer's disease	1.82e-05	0.000183	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—AKT1—Alzheimer's disease	1.79e-05	0.000179	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.78e-05	0.000179	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PRKCG—Alzheimer's disease	1.75e-05	0.000175	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NPY—Alzheimer's disease	1.74e-05	0.000175	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IAPP—Alzheimer's disease	1.73e-05	0.000174	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	1.68e-05	0.000168	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	1.65e-05	0.000166	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.62e-05	0.000163	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	1.59e-05	0.00016	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.58e-05	0.000159	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.58e-05	0.000159	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.58e-05	0.000159	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	1.56e-05	0.000157	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	1.56e-05	0.000157	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SST—Alzheimer's disease	1.52e-05	0.000152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	1.52e-05	0.000152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	1.52e-05	0.000152	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.51e-05	0.000152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	1.51e-05	0.000152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	1.5e-05	0.000151	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APP—Alzheimer's disease	1.48e-05	0.000148	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.46e-05	0.000146	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	1.42e-05	0.000143	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—A2M—Alzheimer's disease	1.41e-05	0.000141	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	1.39e-05	0.00014	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	1.3e-05	0.000131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	1.29e-05	0.00013	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	1.27e-05	0.000128	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	1.27e-05	0.000127	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ACHE—Alzheimer's disease	1.23e-05	0.000123	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	1.21e-05	0.000122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	1.2e-05	0.000121	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	1.15e-05	0.000115	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ENO1—Alzheimer's disease	1.15e-05	0.000115	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	1.14e-05	0.000115	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	1.11e-05	0.000111	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—BCHE—Alzheimer's disease	1.07e-05	0.000107	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	1.06e-05	0.000107	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	1.05e-05	0.000106	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	1.03e-05	0.000104	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	1.01e-05	0.000101	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	1e-05	0.000101	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	9.77e-06	9.82e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	9.76e-06	9.81e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	9.56e-06	9.61e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	8.92e-06	8.96e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	8.89e-06	8.93e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	8.89e-06	8.93e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	8.81e-06	8.85e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	8.49e-06	8.53e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	8.41e-06	8.45e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—F2—Alzheimer's disease	8.39e-06	8.42e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	8.37e-06	8.41e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	8.21e-06	8.24e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	7.7e-06	7.74e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LPL—Alzheimer's disease	7.66e-06	7.7e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	7.64e-06	7.67e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—INS—Alzheimer's disease	7.6e-06	7.63e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	7.47e-06	7.51e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	7.35e-06	7.38e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	6.9e-06	6.93e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	6.66e-06	6.69e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CALM1—Alzheimer's disease	6.44e-06	6.47e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APOE—Alzheimer's disease	6.42e-06	6.45e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CAV1—Alzheimer's disease	6.36e-06	6.39e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	5.71e-06	5.73e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	5.66e-06	5.68e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	5.62e-06	5.65e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPARG—Alzheimer's disease	5.59e-06	5.62e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—INS—Alzheimer's disease	5.49e-06	5.51e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	5.2e-06	5.22e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	5.18e-06	5.21e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NOS3—Alzheimer's disease	4.81e-06	4.83e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	4.8e-06	4.82e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	4.4e-06	4.43e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	4.4e-06	4.42e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	3.63e-06	3.64e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	3.32e-06	3.33e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	3.06e-06	3.08e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AKT1—Alzheimer's disease	2.21e-06	2.22e-05	CbGpPWpGaD
